Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Clinical trial NCT01404312 · COMPLETED
Trial details
- NCT number
- NCT01404312
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-23
- Primary completion
- 2017-11-14
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.